MapLight Therapeutics Inc (MPLT)

Currency in USD
0.00
0.00(0.00%)
Closed·
MPLT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.000.00
52 wk Range
0.000.00
Key Statistics
Prev. Close
-
Open
-
Day's Range
-
52 wk Range
0-0
Volume
-
Average Volume (3m)
-
1-Year Change
-
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MPLT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Neutral
Moving Averages
Strong Sell

MapLight Therapeutics Inc Company Profile

MapLight Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous system disorders. The company’s products include ML-007C-MA, a fixed-dose combination of an M 1 /M 4 muscarinic agonist for the treatment of schizophrenia and Alzheimer’s disease psychosis; ML-004 for the treatment of social communication deficit and/or irritability in autism spectrum disorder; ML-021 for the treatment of motor deficits in Parkinson’s disease; and ML-009, a G-protein-coupled receptor 52 positive allosteric modulator for the treatment of hyperactivity, impulsivity and agitation-related disorders. The company also develops platform identifying neural circuits causally linked to disease and targeting those circuits for therapeutic modulation. MapLight Therapeutics, Inc. was formerly known as Alvarado Therapeutics, Inc. and changed its name to MapLight Therapeutics, Inc. in August 2019. MapLight Therapeutics, Inc. was incorporated in 2018 and is based in Redwood City, California. MapLight Therapeutics, Inc operates as a subsidiary of Catalyst4, Inc.

Industry
-
Sector
-
Employees
109

Compare MPLT to Peers and Sector

Metrics to compare
MPLT
Peers
Sector
Relationship
P/E Ratio
UnlockNaNNaNUnlock
PEG Ratio
UnlockNaNNaNUnlock
Price/Book
UnlockNaNNaNUnlock
Price / LTM Sales
UnlockNaNNaNUnlock
Upside (Analyst Target)
UnlockNaNNaNUnlock
Fair Value Upside
UnlockNaNNaNUnlock

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

MPLT Income Statement

FAQ

What Stock Exchange Does MapLight Therapeutics Trade On?

MapLight Therapeutics is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for MapLight Therapeutics?

The stock symbol for MapLight Therapeutics is "MPLT."

What Is MapLight Therapeutics's Earnings Per Share (TTM)?

The MapLight Therapeutics EPS (TTM) is -121.50.

From a Technical Analysis Perspective, Is MPLT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has MapLight Therapeutics Stock Split?

MapLight Therapeutics has split 0 times.

How Many Employees Does MapLight Therapeutics Have?

MapLight Therapeutics has 109 employees.

What is the current trading status of MapLight Therapeutics (MPLT)?

As of 24 Oct 2025, MapLight Therapeutics (MPLT) is trading at a price of 0.00, with a previous close of 0.00. The stock has fluctuated within a day range of 0.00 to 0.00, while its 52-week range spans from 0.00 to 0.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.